---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-057694"
form_type: "8-K"
ticker: "ALKS"
cik: "0001520262"
company_name: "Alkermes plc."
filed_at: "2021-11-19T23:59:59+00:00"
generated_at: "2026-06-28T06:32:06.228037+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Alkermes appoints Dr. Cato T. Laurencin to Board under Sarissa Capital agreement

## Summary
- Dr. Cato T. Laurencin appointed as Class II director effective Nov 18, 2021; term expires at 2022 AGM.
- Sarissa Capital exercised its right to designate a director per the April 2021 agreement.
- Laurencin is a University of Connecticut professor specializing in regenerative engineering and health disparities.
- He will receive standard director compensation (equity grant and cash retainer) in December 2021.
- Board expanded to 12 directors; this is the sixth new independent director since 2019.

## SEC filing metadata
- accession: 0001564590-21-057694
- form_type: 8-K
- ticker: ALKS
- cik: 0001520262
- company_name: Alkermes plc.
- filed_at: 2021-11-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1520262/000156459021057694/0001564590-21-057694-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1520262/000156459021057694/alks-8k_20211118.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-057694
- JSON: https://secwatch.observer/filing/0001564590-21-057694.json
- Plain text: https://secwatch.observer/filing/0001564590-21-057694.txt

## Key facts
- Executive change
  Dr. Cato T. Laurencin was elected as Director at Alkermes plc..
  - Action: elected
  - Role: Director
  source text: On November 18, 2021, the Board of Directors (the “Board”) of Alkermes plc (the “Company”) increased the size of the Board to twelve (12) directors and elected Dr. Cato T. Laurencin to the Board, effective immediately, as a Class II member with a term expiring at the Company’s 2022 annual general meeting of shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1520262/000156459021057694/0001564590-21-057694-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.